APA (7th ed.) Citation

K, P., S, K., L, S., M, A., C, L., WK, K., . . . O, D. (2025). Prognostic utility of mid-regional pro-adrenomedullin and growth differentiation factor 15 in patients undergoing transfemoral transcatheter aortic valve implantation. Clinical research in cardiology : official journal of the German Cardiac Society, 114(11), 1508. https://doi.org/10.1007/s00392-024-02560-w

Chicago Style (17th ed.) Citation

K, Piayda, et al. "Prognostic Utility of Mid-regional Pro-adrenomedullin and Growth Differentiation Factor 15 in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation." Clinical Research in Cardiology : Official Journal of the German Cardiac Society 114, no. 11 (2025): 1508. https://doi.org/10.1007/s00392-024-02560-w.

MLA (9th ed.) Citation

K, Piayda, et al. "Prognostic Utility of Mid-regional Pro-adrenomedullin and Growth Differentiation Factor 15 in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation." Clinical Research in Cardiology : Official Journal of the German Cardiac Society, vol. 114, no. 11, 2025, p. 1508, https://doi.org/10.1007/s00392-024-02560-w.